Cardiome Pharma Corp. (USA) (NASDAQ:CRME)

CAPS Rating: 3 out of 5

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

Recs

0
Player Avatar gravmic (< 20) Submitted: 5/16/2011 3:20:17 PM : Outperform Start Price: $5.35 CRME Score: -90.74

magic formula

Featured Broker Partners


Advertisement